Drugmakers are developing new iterations of GLP-1 weight loss drugs that could result in fewer side effects. According to a news item in Becker’s Hospital Review, 27 GLP-1 drugs are in development, but the majority of the data is based on animal studies or early-stage human trials. In one example, researchers are optimistic about the experimental drug petrelinitide, which was shown to reduce body weight by an average of nearly 9% at 16 weeks. It …
Read More![Substantial Number of GLP-1 Drugs in the Pipeline Hint at Lower Future Costs Substantial Number of GLP-1 Drugs in the Pipeline Hint at Lower Future Costs](https://www.jucm.com/wp-content/uploads/2024/06/GLP-pipeline-FemaleStanding-in-Front-of-Green-Cabinets-Medicine-Cabinet-380x253-1.jpg)